Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 786 publications

Recent Advances in One-Pot Multicomponent Reactions for the Synthesis of Substituted Quinazolin-4(3H)-ones.

Recent Advances in One-Pot Multicomponent Reactions for the Synthesis of Substituted Quinazolin-4(3H)-ones.

Journal: Molecules (Basel, Switzerland)
Published: August 14, 2025

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Journal: Hematology/oncology clinics of North America
Published: July 01, 2025

Inhibition of PI3K/AKT/mTOR signaling enhances autophagy in HL-60 acute myeloid leukemia cells: An integrative bioinformatic and in vitro study.

Inhibition of PI3K/AKT/mTOR signaling enhances autophagy in HL-60 acute myeloid leukemia cells: An integrative bioinformatic and in vitro study.

Journal: Biochemistry and biophysics reports
Published: May 29, 2025

Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions.

Targeted therapies and resistance mechanisms in lymphoma: Current landscape and emerging solutions.

Journal: Oncoscience
Published: May 29, 2025

PLEKHG7 Expression: A Biomarker for Prognosis and Targeted Therapy in Diffuse Large B-cell Lymphoma.

PLEKHG7 Expression: A Biomarker for Prognosis and Targeted Therapy in Diffuse Large B-cell Lymphoma.

Journal: Protein and peptide letters
Published: April 10, 2025

Novel PI3Kδ inhibitor exerts antitumor activity in Burkitt lymphoma by inducing ROS-dependent apoptosis.

Novel PI3Kδ inhibitor exerts antitumor activity in Burkitt lymphoma by inducing ROS-dependent apoptosis.

Journal: Medical oncology (Northwood, London, England)
Published: April 03, 2025

Loss of PI3Kδ Activity Drives Autoimmune Colitis by Impairing Extrathymic Treg Differentiation.

Loss of PI3Kδ Activity Drives Autoimmune Colitis by Impairing Extrathymic Treg Differentiation.

Journal: European journal of immunology
Published: April 01, 2025

Cutaneous Acanthamoebiasis: Two Cases Highlighting Diverse Histopathologic Findings.

Cutaneous Acanthamoebiasis: Two Cases Highlighting Diverse Histopathologic Findings.

Journal: Journal of cutaneous pathology
Published: March 21, 2025

A long-lasting PI3Kδ inhibitor zandelisib forms a water-shielded hydrogen bond with p110δ and demonstrates sustained inhibitory effects.

A long-lasting PI3Kδ inhibitor zandelisib forms a water-shielded hydrogen bond with p110δ and demonstrates sustained inhibitory effects.

Journal: American journal of cancer research
Published: March 20, 2025

Idelalisib modulates CD4+ T cell responses to mitigate rejection of allografts in mice.

Idelalisib modulates CD4+ T cell responses to mitigate rejection of allografts in mice.

Journal: International immunopharmacology
Published: March 19, 2025

Investigating the impact of berberine on autophagy-mediated drug resistance in chronic lymphocytic leukemia tumor cells.

Investigating the impact of berberine on autophagy-mediated drug resistance in chronic lymphocytic leukemia tumor cells.

Journal: Medical oncology (Northwood, London, England)
Published: March 03, 2025

JMC14: a novel dual PI3Kδ/CSF1R inhibitor with potent antitumor activity in hematological and solid tumors.

JMC14: a novel dual PI3Kδ/CSF1R inhibitor with potent antitumor activity in hematological and solid tumors.

Journal: Acta pharmacologica Sinica
Published: January 25, 2025
Showing 1-12 of 786

Last Updated: 10/31/2025